Edition:
United Kingdom

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

4.99USD
14 Dec 2017
Change (% chg)

$-0.21 (-4.04%)
Prev Close
$5.20
Open
$5.13
Day's High
$5.13
Day's Low
$4.99
Volume
2,954
Avg. Vol
6,760
52-wk High
$10.75
52-wk Low
$3.04

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Avner Rotman

74 2005 Chairman of the Board

Ron Babecoff

54 2003 Chief Executive Officer, President, Director

Uri Ben-Or

47 2007 Chief Financial Officer

Tamar Ben-Yedidia

53 2004 Chief Scientific Officer

Yisrael Gewirtz

40 2014 Internal Auditor